Neural Regeneration Research ›› 2018, Vol. 13 ›› Issue (12): 2105-2107.doi: 10.4103/1673-5374.241459

Previous Articles     Next Articles

Cell-based therapy in Alzheimer’s disease: can human fetal cholinergic neurons “untangle the skein”?

Giulia Guarnieri, Erica Sarchielli, Gabriella B. Vannelli, Annamaria Morelli   

  1. Anatomy and Histology Unit, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Received:2018-08-13 Online:2018-12-15 Published:2018-12-15
  • Contact: Annamaria Morelli, PhD, a.morelli@unifi.it.

Abstract:

Alzheimer’s disease (AD) is a devastating neurodegenerative disorder and the most common form of old-age dementia. The disease is characterized by a progressive decline in cognitive functions, gradual loss of memory and ability to perform everyday activities, and leads to inevitable death within 3 to 9 years after diagnosis. The pathological hallmarks of the disease are the accumulation of intracellular neurofibrillary tangles, composed of the microtubule associated protein tau, and extracellular deposits of amyloid-β (Aβ) plaques, which are overall responsible for an extensive loss of neurons and synaptic connectivity.